161 related articles for article (PubMed ID: 34719043)
1. Medication control of flunixin in racing horses: Possible detection times using Monte Carlo simulations.
Kuroda T; Minamijima Y; Nomura M; Yamashita S; Yamada M; Nagata S; Mita H; Tamura N; Fukuda K; Kuwano A; Kusano K; Toutain PL; Sato F
Equine Vet J; 2022 Sep; 54(5):979-988. PubMed ID: 34719043
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of transdermal flunixin meglumine and effects on biomarkers of inflammation in horses.
Knych HK; Arthur RM; Gretler SR; McKemie DS; Goldin S; Kass PH
J Vet Pharmacol Ther; 2021 Sep; 44(5):745-753. PubMed ID: 34173263
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and anti-inflammatory effects of flunixin meglumine as a sole agent and in combination with phenylbutazone in exercised Thoroughbred horses.
Knych HK; Arthur RM; McKemie DS; Baden RW; Seminoff K; Kass PH
Equine Vet J; 2021 Jan; 53(1):102-116. PubMed ID: 32145701
[TBL] [Abstract][Full Text] [Related]
4. Kinetic disposition of diazepam and its metabolites after intravenous administration of diazepam in the horse: Relevance for doping control.
Schenk I; Machnik M; Broussou D; Meuly A; Roques BB; Lallemand E; Düe M; Röttgen H; Lagershausen H; Toutain PL; Thevis M
J Vet Pharmacol Ther; 2021 Sep; 44(5):733-744. PubMed ID: 34115414
[TBL] [Abstract][Full Text] [Related]
5. Control of methylxanthines in the competition horse: pharmacokinetic/pharmacodynamic studies on caffeine, theobromine and theophylline for the assessment of irrelevant concentrations.
Machnik M; Kaiser S; Koppe S; Kietzmann M; Schenk I; Düe M; Thevis M; Schänzer W; Toutain PL
Drug Test Anal; 2017 Sep; 9(9):1372-1384. PubMed ID: 27662634
[TBL] [Abstract][Full Text] [Related]
6. Quantification and confirmation of flunixin in equine plasma by liquid chromatography-quadrupole time-of-flight tandem mass spectrometry.
Luo Y; Rudy JA; Uboh CE; Soma LR; Guan F; Enright JM; Tsang DS
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Mar; 801(2):173-84. PubMed ID: 14751785
[TBL] [Abstract][Full Text] [Related]
7. Rational determination of cefazolin dosage regimen in horses based on pharmacokinetics/pharmacodynamics principles and Monte Carlo simulations.
Kuroda T; Minamijima Y; Mita H; Tamura N; Fukuda K; Kuwano A; Toutain PL; Sato F
J Vet Pharmacol Ther; 2023 Jan; 46(1):62-67. PubMed ID: 36245288
[TBL] [Abstract][Full Text] [Related]
8. Plasma and urine pharmacokinetics of intravenously administered flunixin in greyhound dogs.
Morris T; Paine SW; Zahra P; Li E; Colgan S; Karamatic S
J Vet Pharmacol Ther; 2019 Sep; 42(5):505-510. PubMed ID: 31090076
[TBL] [Abstract][Full Text] [Related]
9. Detection and identification of flunixin after multiple intravenous and intramuscular doses to horses.
Sams RA; Gerken DF; Ashcraft SM
J Anal Toxicol; 1999 Sep; 23(5):372-9. PubMed ID: 10488926
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of flunixin meglumine in healthy foals less than twenty-four hours old.
Crisman MV; Wilcke JR; Sams RA
Am J Vet Res; 1996 Dec; 57(12):1759-61. PubMed ID: 8950431
[TBL] [Abstract][Full Text] [Related]
11. Plasma and urine pharmacokinetics of hydroxyzine and cetirizine following repeated oral administrations to exercised horses.
Paine SW; Aldurdunji M; Garth-Greeves A; Muir T; Hincks PR
J Vet Pharmacol Ther; 2022 Jan; 45(1):46-53. PubMed ID: 34469007
[TBL] [Abstract][Full Text] [Related]
12. Plasma concentrations of flunixin in the horse: its relationship to thromboxane B2 production.
Soma LR; Uboh CE; Rudy J; Fegely J
J Vet Pharmacol Ther; 1992 Sep; 15(3):292-300. PubMed ID: 1433493
[TBL] [Abstract][Full Text] [Related]
13. Use of force plate analysis to compare the analgesic effects of intravenous administration of phenylbutazone and flunixin meglumine in horses with navicular syndrome.
Erkert RS; MacAllister CG; Payton ME; Clarke CR
Am J Vet Res; 2005 Feb; 66(2):284-8. PubMed ID: 15757129
[TBL] [Abstract][Full Text] [Related]
14. Comparison of ELISA and LC-MS/MS for the measurement of flunixin plasma concentrations in beef cattle after intravenous and subcutaneous administration.
Shelver WL; Tell LA; Wagner S; Wetzlich SE; Baynes RE; Riviere JE; Smith DJ
J Agric Food Chem; 2013 Mar; 61(11):2679-86. PubMed ID: 23470029
[TBL] [Abstract][Full Text] [Related]
15. Long-term monitoring of opioid, sedative and anti-inflammatory drugs in horse hair using a selective and sensitive LC-MS/MS procedure.
Madry MM; Spycher BS; Kupper J; Fuerst A; Baumgartner MR; Kraemer T; Naegeli H
BMC Vet Res; 2016 Jun; 12():84. PubMed ID: 27250835
[TBL] [Abstract][Full Text] [Related]
16. Novel holistic pharmacokinetic model applied to plasma and urine concentrations of 2,5-dihydroxybenzene sulphonate following administrations of calcium dobesilate and etamsylate to exercised horses.
Paine SW; Harding C; Waller CC; Zemenova J; Viljanto M; Habershon Butcher J; Hincks PR
J Vet Pharmacol Ther; 2023 Nov; 46(6):365-374. PubMed ID: 37255256
[TBL] [Abstract][Full Text] [Related]
17. Effect of firocoxib or flunixin meglumine on recovery of ischemic-injured equine jejunum.
Cook VL; Meyer CT; Campbell NB; Blikslager AT
Am J Vet Res; 2009 Aug; 70(8):992-1000. PubMed ID: 19645580
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of flunixin meglumine in donkeys, mules, and horses.
Coakley M; Peck KE; Taylor TS; Matthews NS; Mealey KL
Am J Vet Res; 1999 Nov; 60(11):1441-4. PubMed ID: 10566824
[TBL] [Abstract][Full Text] [Related]
19. Effect of age on the pharmacokinetics and pharmacodynamics of flunixin meglumine following intravenous and transdermal administration to Holstein calves.
Kleinhenz MD; Van Engen NK; Gorden PJ; Smith JS; KuKanich B; Rajewski SM; Walsh P; Perkins S; Coetzee JF
Am J Vet Res; 2018 May; 79(5):568-575. PubMed ID: 29688783
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of clodronate disodium evaluated in plasma, synovial fluid and urine.
Krueger CR; Mitchell CF; Leise BS; Knych HK
Equine Vet J; 2020 Sep; 52(5):725-732. PubMed ID: 32003488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
